BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4136566)

  • 1. Biophysical differentiation between lymphocytes from healthy donors, patients with malignant diseases and other disorders.
    Cercek L; Cercek B; Franklin CI
    Br J Cancer; 1974 May; 29(5):345-52. PubMed ID: 4136566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the structuredness of cytoplasmic matrix (SCM) in human lymphocytes induced by PHA and cancer basic protein as measured in single cells.
    Cercek L; Cercek B
    Br J Cancer; 1976 May; 33(5):539-43. PubMed ID: 1276032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.
    Cercek L; Cercek B
    Eur J Cancer (1965); 1977 Sep; 13(9):903-15. PubMed ID: 334557
    [No Abstract]   [Full Text] [Related]  

  • 4. Differentiation between patients with malignant diseases and non-malignant diseases or healthy donors by changes of fluorescence polarization in the cytoplams of circulating lymphocytes.
    Hashimoto Y; Yamanaka T; Takaku F
    Gan; 1978 Apr; 69(2):145-9. PubMed ID: 680459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour specificity of the SCM test for cancer diagnosis.
    Chaitchik S; Asher O; Deutsch M; Weinreb A
    Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1165-70. PubMed ID: 2416568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of human lymphocytes to PHA and tumour-associated antigens as detected by fluorescence polarization.
    Balding P; Light PA; Preece AW
    Br J Cancer; 1980 Jan; 41(1):73-85. PubMed ID: 6153900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fluorescence polarization of human blood lymphocytes (SCM test) in the diagnosis of cancer.
    Schnuda ND
    Cancer; 1980 Sep; 46(5):1164-73. PubMed ID: 7214300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cyclic-AMP in changes of the structuredness of cytoplasmic matrix (SCM).
    Cercek L; Cercek B
    Radiat Environ Biophys; 1974; 11(3):209-12. PubMed ID: 4373773
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial: A blood-lymphocyte test for cancer?
    Lancet; 1974 Aug; 2(7876):327-8. PubMed ID: 4136185
    [No Abstract]   [Full Text] [Related]  

  • 10. New SCM (structuredness of the cytoplasmatic matrix)-based approach in breast cancer detection.
    Birindelli S; Colnaghi MI; Pilotti S
    Tumori; 1996; 82(6):550-3. PubMed ID: 9061062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of colon cancer by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Duetsch M; Tirosh R; Wohl I; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1996; 20(4):300-7. PubMed ID: 8818390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of osmomolarity, calcium and magnesium ions on the structuredness of cytoplasmic matrix (SCM).
    Cercek L; Cercek B
    Radiat Environ Biophys; 1976 Mar; 13(1):9-12. PubMed ID: 959479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of melanoma by monitoring the intracellular fluorescein fluorescence polarization changes in lymphocytes.
    Merimsky O; Kaplan B; Deutsch M; Tirosh R; Weinreb A; Chaitchik S
    Cancer Detect Prev; 1997; 21(2):167-77. PubMed ID: 9101078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The SCM test for cancer. an evaluation in terms of lymphocytes from healthy donors and cancer patients.
    Mitchell H; Wood P; Pentycross CR; Abel E; Bagshawe KD
    Br J Cancer; 1980 May; 41(5):772-7. PubMed ID: 6158967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent tumour specificity with the SCM test.
    Cercek L; Cercek B
    Br J Cancer; 1975 Feb; 31(2):252-3. PubMed ID: 1164473
    [No Abstract]   [Full Text] [Related]  

  • 16. Suppression by serum of immunoreactivity to a common tumour antigen in cancer patients.
    Koppi TA; Khan JM; Halliday WJ
    Oncology; 1984; 41(2):77-82. PubMed ID: 6200811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
    Hashimoto Y; Takaku F; Yamanaka T
    Br J Cancer; 1979 Jul; 40(1):156-60. PubMed ID: 454560
    [No Abstract]   [Full Text] [Related]  

  • 18. Induction of PHA response in mouse bone marrow cells by thymic extracts as studied by changes in the structuredness of cytoplasmic matrix.
    Cercek L; Milenkovic P; Cercek B; Lajtha LG
    Immunology; 1975 Nov; 29(5):885-91. PubMed ID: 1081487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the SCM response ratio (RRscm) after surgical removal of malignant tissue.
    Cercek L; Cercek B
    Br J Cancer; 1975 Feb; 31(2):250-1. PubMed ID: 1164472
    [No Abstract]   [Full Text] [Related]  

  • 20. An approach for high sensitivity detection of prostate cancer by analysis of changes in structuredness of the cytoplasmic matrix of lymphocytes specifically induced by PSA-ACT.
    Klein O; Lin S; Embon O; Sazbon A; Zidan J; Kook AI
    J Urol; 1999 Jun; 161(6):1994-6. PubMed ID: 10332488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.